Seung-Kee Moon

Title: Seung-Kee Moon: Innovator in Antibody Technology

Introduction

Seung-Kee Moon is a prominent inventor based in Yongin-si, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of antibody variants and expression vectors for animal cells. With a total of four patents to his name, Moon's work has the potential to impact cancer treatment and the production of recombinant proteins.

Latest Patents

One of Moon's latest patents is for anti-ErbB2 antibody variants. This invention relates to antibody variants or antigen-binding fragments that can bind to ErbB2 with high affinity. These variants are designed to effectively prevent or treat various cancers with a minimal dosage. Another notable patent is for an expression vector for animal cells that includes CSP-B 5'-SAR factor. This vector is crucial for producing recombinant proteins, as it overcomes gene expression inhibition and significantly enhances the expression rate of target proteins. The applications of this vector are particularly valuable for the industrial mass production of drugs.

Career Highlights

Seung-Kee Moon is currently associated with Chong Kun Dang Pharmaceutical Corporation, where he continues to innovate in the field of pharmaceuticals. His work is characterized by a strong focus on developing solutions that can lead to more effective treatments and production methods in the biotechnology sector.

Collaborations

Moon collaborates with notable colleagues such as Nam-Song Choi and Young-Hoon Kim, contributing to a dynamic research environment that fosters innovation and advancement in their respective fields.

Conclusion

Seung-Kee Moon's contributions to biotechnology, particularly in antibody technology and protein production, highlight his role as a key innovator in the industry. His patents reflect a commitment to improving healthcare solutions and advancing scientific knowledge.